← Leaderboards
John C Stendahl
Yale University
$648,420
Attributed
$648,420
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $162.1K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$648,420 · 1
By mechanism
K08$648,420 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Albert J Sinusas$22,904,679
- James S Duncan$40,355,994
- Robert Soufer$5,618,914
- Jordan S Pober$30,894,969
- George Tellides$10,774,220
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectAntibodiesAllogenicBiomedical EngineeringBlood FlowBlood VesselsCardiacCardiopulmonary BypassCardiovascular ImagingCardiovascular SystemCareerClinically SignificantCollaborationsCoronaryCoronary ArteryCoronary VasculatureDesignDiagnostic ImagingDoctor Of PhilosophyDocumentationDrug CarriersEchocardiographyEngineeringEquipment
Grant awards (4)
Targeted delivery of nanomedicines to the coronary microvasculature during ex vivo normothermic perfusion of marginal human hearts$162,105
K08 · FY2025 · HL · contact PI
Targeted delivery of nanomedicines to the coronary microvasculature during ex vivo normothermic perfusion of marginal human hearts$162,105
K08 · FY2024 · HL · contact PI
Targeted delivery of nanomedicines to the coronary microvasculature during ex vivo normothermic perfusion of marginal human hearts$162,105
K08 · FY2023 · HL · contact PI
Targeted delivery of nanomedicines to the coronary microvasculature during ex vivo normothermic perfusion of marginal human hearts$162,105
K08 · FY2022 · HL · contact PI